Cancer Genome Characterization Initiative
Point of Contact: Center for Cancer Genomics, NCICCGenomics@mail.nih.gov
Program
The Cancer Genome Characterization Initiative (CGCI) uses molecular characterization to uncover distinct features of rare cancers. Current projects perform comprehensive molecular cataloging of HIV+ and other rare adult and pediatric cancers. The CGCI Data Matrix is a high-level catalog of data generated by the Initiative, with links to the sites where the controlled access data are hosted. The projects described on CGCI pages include Burkitt Lymphoma, HIV+ Tumor Molecular Characterization Project, Medulloblastoma-Complete, and Non-Hodgkin Lymphoma-Complete.
Resource Description
Resource Type
Program
Specialization
Pediatric
Data Update Date
07/23/2024
Data Content Type
Clinical, Genomics/Omics, Imaging
Resource Tools
Visualization Tools
Analytic Tools
Case Disease Diagnosis
B-Cell Lymphoma, Nos (1); B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma And Burkitt Lymphoma (1); Burkitt Lymphoma, NOS (158); Burkitt-like Lymphoma (14); Tumor, NOS (2)
Number of Cases
176
Case Sex
Female (56); Male (120)
Case Age At Diagnosis
0 to 4 years (26); 5 to 9 years (79); 10 to 14 years (22); 15 to 19 years (15); 20 to 24 years (8); 25 to 29 years (15); 30 to 34 years (8); 35 to 39 years (3)
Published In
Project
Case Disease Diagnosis
Adenocarcinoma, NOS (2); Diffuse Large B-cell Lymphoma, NOS (12); Kaposi Sarcoma (1); Lymphoepithelial Carcinoma (1); Squamous Cell Carcinoma, Keratinizing, NOS (5); Squamous Cell Carcinoma, Nonkeratinizing, NOS (14); Not Reported (1)
Number of Cases
36
Case Sex
Female (25); Male (11)
Case Age At Diagnosis
0 to 4 years (1); 5 to 9 years (1); 10 to 14 years (2); 15 to 19 years (1); 25 to 29 years (6); 30 to 34 years (12); 35 to 39 years (13)
Published In
Project